Just over a week after announcing positive data from a pharmacokinetic similarity study for its AVT04 ustekinumab candidate, Alvotech has revealed further success in a confirmatory clinical safety and efficacy study for the proposed biosimilar to Stelara.
Alvotech’s Ustekinumab Passes Safety And Efficacy Milestone
Company Reports Fresh Data For AVT04 Biosimilar Rival To Stelara
Alvotech has announced success in its confirmatory clinical safety and efficacy study for its AVT04 ustekinumab candidate, a proposed biosimilar to Stelara.
